Clinical Trial 11971

Pasadena, CA 91105

Study Summary:

Physicians at approximately 25 clinics in the US are conducting a research study to test the safety and effectiveness of an injectable investigational treatment to determine if it can slow the rate of Alzheimer’s disease progression.

We are looking for people with probable Alzheimer’s disease, and their caregivers, to participate.

To be eligible, participants must be:

  • 50-89 years old
  • Diagnosed with probable Alzheimer’s disease
  • Living at home, or in a community dwelling, with an appropriate caregiver able to accompany participant on all study visits as well as visit participant at home at least 5 times a week
Participants will continue to take their current Alzheimer’s medication during the study, as well as the injectable investigational treatment for approximately 2 years.

Qualified Participants May Receive:

All study-related office visits, medical examinations, and injectable investigational treatment will be provided at no cost.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.